(RS)-(4,4-difluoro-3-(quinolin-2-yloxy)piperidin-1-yl)(phenyl)methanone

ID: ALA3932393

PubChem CID: 134137910

Max Phase: Preclinical

Molecular Formula: C21H18F2N2O2

Molecular Weight: 368.38

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(c1ccccc1)N1CCC(F)(F)C(Oc2ccc3ccccc3n2)C1

Standard InChI:  InChI=1S/C21H18F2N2O2/c22-21(23)12-13-25(20(26)16-7-2-1-3-8-16)14-18(21)27-19-11-10-15-6-4-5-9-17(15)24-19/h1-11,18H,12-14H2

Standard InChI Key:  GREGEUCGFKPDRT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   16.6410  -22.7906    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.0537  -23.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4621  -22.7881    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.9515  -26.3771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9504  -27.1966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6584  -27.6056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6566  -25.9682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3653  -26.3735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3687  -27.1987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0743  -25.9557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7856  -26.3580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0670  -25.1385    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7714  -24.7216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7661  -23.9080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3508  -23.9155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3544  -24.7353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4717  -23.4956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1815  -23.9005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1808  -24.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8898  -25.1197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8798  -23.4849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5894  -23.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5923  -24.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3009  -25.1084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0071  -24.6963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0001  -23.8753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2910  -23.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 14  2  1  0
  2 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 23  2  0
 22 21  2  0
 21 18  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3932393

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 368.38

Molecular Weight (Monoisotopic): 368.1336

AlogP: 4.16

#Rotatable Bonds: 3

Polar Surface Area: 42.43

Molecular Species: NEUTRAL

HBA: 3

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.22

CX LogP: 4.53

CX LogD: 4.53

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.70

Np Likeness Score: -0.91

References

1. Stump CA, Cooke AJ, Bruno J, Cabalu TD, Gotter AL, Harell CM, Kuduk SD, McDonald TP, O'Brien J, Renger JJ, Williams PD, Winrow CJ, Coleman PJ..  (2016)  Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology.,  26  (23): [PMID:27818110] [10.1016/j.bmcl.2016.10.019]

Source

Source(1):

• Scientific Literature